CONMED (CNMD) Short Interest Ratio & Short Volume $72.24 +1.05 (+1.47%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CONMED Short Interest DataCONMED (CNMD) has a short interest of 2.26 million shares. This marks a -8.13% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.7, indicating that it would take 5.7 days of the average trading volume of 467,344 shares to cover all short positions.Current Short Interest2,260,000 sharesPrevious Short Interest2,460,000 sharesChange Vs. Previous Month-8.13%Dollar Volume Sold Short$154.34 millionShort Interest Ratio5.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares30,890,000 sharesPercentage of Shares Shorted7.32%Today's Trading Volume335,985 sharesAverage Trading Volume467,344 sharesToday's Volume Vs. Average72% Short Selling CONMED? Sign up to receive the latest short interest report for CONMED and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCNMD Short Interest Over TimeCNMD Days to Cover Over TimeCNMD Percentage of Float Shorted Over Time Ad Traders Agency5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.Click here to pay just $5 for a full year of Stealth Trades CONMED Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20242,260,000 shares $154.34 million -8.1%N/A5.7 $68.29 10/15/20242,460,000 shares $159.43 million -3.2%N/A5.9 $64.81 9/30/20242,540,000 shares $182.70 million -16.5%N/A5.9 $71.93 9/15/20243,040,000 shares $229.22 million -6.5%N/A7.2 $75.40 8/31/20243,250,000 shares $237.97 million +1.9%N/A7.7 $73.22 8/15/20243,190,000 shares $213.06 million -10.9%N/A7.4 $66.79 Get the Latest News and Ratings for CNMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter. 7/31/20243,580,000 shares $247.38 million -11.6%N/A8 $69.10 7/15/20244,050,000 shares $277.18 million +4.9%N/A8.3 $68.44 6/30/20243,860,000 shares $267.58 million -0.5%N/A7.8 $69.32 6/15/20243,880,000 shares $275.91 million +0.3%N/A7.7 $71.11 5/31/20243,870,000 shares $295.82 million +5.7%N/A7.4 $76.44 5/15/20243,660,000 shares $272.71 million +5.2%N/A7 $74.51 4/30/20243,480,000 shares $236.61 million -10.5%N/A6.4 $67.99 4/15/20243,890,000 shares $292.57 million -4.4%N/A6.6 $75.21 3/31/20244,070,000 shares $325.93 million +3.6%N/A7.3 $80.08 3/15/20243,930,000 shares $304.38 million -0.8%N/A7.1 $77.45 2/29/20243,960,000 shares $318.03 million -2.2%N/A7.6 $80.31 2/15/20244,050,000 shares $339.53 million -15.6%N/A8.1 $83.84 1/31/20244,800,000 shares $458.88 million +11.4%N/A10 $95.60 1/15/20244,310,000 shares $480.74 million -1.4%N/A10.9 $111.54 12/31/20234,370,000 shares $478.56 million -1.4%N/A11.6 $109.51 12/15/20234,430,000 shares $501.17 million -2.9%N/A11.8 $113.13 11/30/20234,560,000 shares $489.54 million -3.4%N/A12.6 $107.36 11/15/20234,720,000 shares $509.15 million +7.8%N/A13.1 $107.87 10/31/20234,380,000 shares $426.79 million +4.8%N/A12.3 $97.44 10/15/20234,180,000 shares $390.33 million +1.0%N/A12.2 $93.38 9/30/20234,140,000 shares $417.52 million +5.6%N/A12 $100.85 9/15/20233,920,000 shares $421.87 million -2.5%N/A11.6 $107.62 8/31/20234,020,000 shares $448.07 million +1.3%N/A11 $111.46 8/15/20233,970,000 shares $444.26 million +0.3%N/A10.5 $111.91 7/31/20233,960,000 shares $479.36 million +5.3%N/A10.4 $121.05 7/15/20233,760,000 shares $506.40 million -5.1%N/A9.8 $134.68 6/30/20233,960,000 shares $538.05 million -7.9%N/A10.7 $135.87 6/15/20234,300,000 shares $586.43 million +3.9%N/A11.2 $136.38 5/31/20234,140,000 shares $502.14 million +0.7%N/A10.7 $121.29 5/15/20234,110,000 shares $498.95 million +3.8%N/A11 $121.40 4/30/20233,960,000 shares $497.26 million -4.4%N/A10.6 $125.57 4/15/20234,140,000 shares $457.55 million -3.7%N/A10.8 $110.52 3/31/20234,300,000 shares $446.60 million +8.9%N/A10.9 $103.86 3/15/20233,950,000 shares $356.92 million +4.2%N/A10.2 $90.362024's Must-Watch Stocks! (Ad)Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] 2/28/20233,790,000 shares $364.56 million -2.3%N/A9.7 $96.19 2/15/20233,880,000 shares $384.74 million +5.4%N/A9.6 $99.16 1/31/20233,680,000 shares $352.40 million +3.1%N/A8.6 $95.76 1/15/20233,570,000 shares $342.68 million -1.4%N/A8.5 $95.99 12/30/20223,620,000 shares $320.88 million +2.0%N/A8.7 $88.64 12/15/20223,550,000 shares $306.33 million +7.3%N/A8.6 $86.29 11/30/20223,310,000 shares $274.23 million -3.2%N/A8.1 $82.85 11/15/20223,420,000 shares $308.11 million +3.6%N/A8.7 $90.09 10/31/20223,300,000 shares $0.00 +5.1%N/A9.1 $0.00 CNMD Short Interest - Frequently Asked Questions What is CONMED's current short interest? Short interest is the volume of CONMED shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 2,260,000 shares of CNMD short. Learn More on CONMED's current short interest. What is a good short interest ratio for CONMED? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CNMD shares currently have a short interest ratio of 6.0. Learn More on CONMED's short interest ratio. Which institutional investors are shorting CONMED? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CONMED: Portman Square Capital LLP, Concourse Financial Group Securities Inc., and Cubist Systematic Strategies LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is CONMED's short interest increasing or decreasing? CONMED saw a decrease in short interest in October. As of October 31st, there was short interest totaling 2,260,000 shares, a decrease of 8.1% from the previous total of 2,460,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CONMED's short interest compare to its competitors? Here is how the short interest of companies in the industry of "medical equipment" compare to CONMED: Penumbra, Inc. (5.89%), Glaukos Co. (4.79%), Bausch + Lomb Co. (2.89%), Stevanato Group S.p.A. (9.07%), Inspire Medical Systems, Inc. (6.51%), PROCEPT BioRobotics Co. (12.05%), Envista Holdings Co. (7.13%), Axonics, Inc. (6.48%), Inari Medical, Inc. (6.30%), TransMedics Group, Inc. (25.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short CONMED stock? Short selling CNMD is an investing strategy that aims to generate trading profit from CONMED as its price is falling. CNMD shares are trading up $1.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CONMED? A short squeeze for CONMED occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNMD, which in turn drives the price of the stock up even further. How often is CONMED's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNMD, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Penumbra Short Squeeze Glaukos Short Squeeze Bausch + Lomb Short Squeeze Stevanato Group Short Squeeze Inspire Medical Systems Short Squeeze PROCEPT BioRobotics Short Squeeze Envista Short Squeeze Axonics Short Squeeze Inari Medical Short Squeeze TransMedics Group Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:CNMD) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CONMED Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CONMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.